Press releases

Non Regulatory

November 12, 2025

Vivesto to hold live-streamed business update on November 24

Regulatory

November 7, 2025

Vivesto reports positive interim results for Paccal Vet pilot study in dogs

Regulatory

November 7, 2025

Nomination Committee appointed for the Annual General Meeting 2026 in Vivesto

Non Regulatory

November 4, 2025

Vivesto receives positive new Cantrixil preclinical results in AML

Non Regulatory

August 14, 2025

First patient dosed in Vivesto’s Paccal Vet dose-finding study in cats

Regulatory

May 8, 2025

Report from Annual General Meeting in Vivesto AB

Regulatory

April 8, 2025

Notice of Annual General Meeting in Vivesto AB

Non Regulatory

April 1, 2025

Vivesto reports positive Cantrixil results in an animal hematological cancer model

Regulatory

March 31, 2025

Vivesto signs deal with Kazia Therapeutics to acquire full Cantrixil rights

Regulatory

March 18, 2025

Vivesto licenses Apealea to China’s Zhida Pharmaceutical

Non Regulatory

January 16, 2025

Vivesto receives approval to initiate a dose-finding study of Paccal Vet in cats